Martin Harutyunyan, Director of OncoDaily LA, shared OncoDaily’s post, adding:
“Last year, I had the pleasure of meeting and interviewing Dr. Mina Sedrak, and his kindness, generosity, and enthusiasm for geriatric oncology left a lasting impression.
I’ll be happy to see him on the American Society of Clinical Oncology (ASCO) Nominating Committee and wholeheartedly recommend him.”
Quoting OncoDaily:
“OncoDaily LA highlights leading oncology voices from Los Angeles who are shaping the future of cancer care.
In this feature, we welcome Dr. Mina Sedrak, Associate Professor of Medicine at UCLA, Director of the Cancer and Aging Program, and Co‑Leader of the Cancer Control and Survivorship Program at the UCLA Health Jonsson Comprehensive Cancer Center.
The interview was conducted by Dr. Martin Harutyunyan.”
The interview also highlights Dr. Sedrak’s research into the relationship between cancer treatment and biological aging, including the development of interventions to preserve long-term health and quality of life among cancer survivors. His work includes the CARG-BC score, an internationally validated tool for predicting chemotherapy toxicity in older women with breast cancer, as well as collaborative research investigating senolytics to address cellular aging, persistent fatigue, and functional decline.
He also emphasizes the need for greater representation of older adults in clinical trials and the importance of integrating survivorship care into the broader cancer treatment journey.
Explore the full interview, ‘Revolutionizing Survivorship: Mina S. Sedrak on Cancer, Aging, and the Science of Time,‘ conducted by Dr. Martin Harutyunyan for OncoDaily LA, to learn more about his research, clinical work, and vision for the future of geriatric oncology.
Read more about Mina Sedrak on OncoDaily.